Smith & Nephew recalls Genesis (GII) surgical devices due to a design flaw in the anterior locking detail that may not meet specifications. Affected models include 71420966 with lot 18JY09702.
“Smith & Nephew Genesis (GII) Surgical Device Recall: Design Flaw Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/64254-smith-nephew-genesis-gii-surgical-device-recall-design-flaw-risk. Based on FDA recall #Z-0118-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0118-2021%22&limit=1).
The FDA announced on September 21, 2020, that Smith & Nephew, Inc. is recalling Genesis (GII) surgical devices because the anterior locking detail does not meet design specifications. The agency classified this as a Class II recall.
How to tell if you have it
Brand: Smith & Nephew, Inc.
Model: 71420966
Lot: 18JY09702
The hazard
The FDA stated that the anterior locking detail of the Genesis (GII) device does not meet its design specifications. The record provides no information regarding incidents or injuries.
Context
GovInfoNow's records show Smith & Nephew, Inc. has 66 other recalls on record since July 24, 2017. Other recent recalls of similar products include the Intuitive Surgical Da Vinci Surgical System Recall (April 22, 2026), the Olympus HX-400U-30 Ligating Device Recall (October 30, 2025), and the Genesis Push-In Suture Anchor Recall (December 17, 2025).
How to tell if you have this one
Check for the Genesis (GII) device model 71420966 with lot number 18JY09702. This device is used in patients with absent or incompetent posterior cruciate ligaments or collateral ligaments during knee surgery.
Brand
Smith & Neph: Inc.
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Device Model
Look for the model number 71420966 and lot number 18JY09702 on the device.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 14 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide distribution - US Nationwide distribution including in the states of CA, NH, NY, GA, MI, TX, IL, OK, LA, OR, FL, AZ, NJ, MO and the countries of AE. BE, BR, CO, DE, ES, FR, GB, HU, IT, PL, PT, TR.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Arizona, California, Florida, Georgia, Illinois, Louisiana, Michigan, Missouri, New Hampshire, New Jersey, New York, Oklahoma, Oregon, Texas.
Recall timeline
FDA terminated this recall 5.7 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The recall states the anterior locking detail may not meet design specifications, but no specific safety issue is described that would cause injury in normal use.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0118-2021 (September 21, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0118-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.